ACARBOSE Side Effects

6914569-6 | Blood Glucose Decreased, Glaucoma
on Aug 02, 2010 Female patient from UNITED STATES , 80 years of age, was diagnosed with diabetes mellitus and was treated with Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, glaucoma (What is glaucoma?). Acarbose dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), GLIPIZIDE (Total Daily Dose: 10 Mg) (View Glipizide Review and Glipizide Label ).

6749086-X | Blood Glucose Decreased, Glaucoma
Patient was taking Acarbose (View Usage). Patient had the following side effects: blood glucose decreased, glaucoma (What is glaucoma?) on Mar 12, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with diabetes mellitus and. Acarbose dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), GLIPIZIDE (Total Daily Dose: 10 Mg) (View Glipizide Review and Glipizide Label ).

6744539-2 | Diarrhoea, Hypokalaemia, Weight Decreased
Adverse event was reported on May 26, 2010 by a Male patient taking Acarbose (View Usage) (Dosage: 50 Mg Tid Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 80 years of age, After Acarbose was administered, patient had the following side effects: diarrhoea, hypokalaemia, weight decreased. Patient was hospitalized.

6714507-5 | Abdominal Distension, Ileus Paralytic, Pneumatosis Intestinalis
on Apr 27, 2010 Female patient from GERMANY , 87 years of age, was diagnosed with diabetes mellitus and was treated with Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, ileus paralytic, pneumatosis intestinalis. Acarbose dosage: 150 Mg, Daily.


6714500-2 | Abdominal Pain, Pneumatosis Intestinalis
on Apr 27, 2010 Female patient from GERMANY , 65 years of age, was diagnosed with diabetes mellitus and was treated with Acarbose (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), pneumatosis intestinalis. Acarbose dosage: 150 Mg, Daily.

6714499-9 | Abdominal Pain, Diarrhoea, Pneumatosis Intestinalis, Weight Decreased
Patient was taking Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, pneumatosis intestinalis, weight decreased on Apr 27, 2010 from GERMANY Additional patient health information: Female patient , 64 years of age, was diagnosed with diabetes mellitus and. Acarbose dosage: Unk Mg, Daily.

6711243-6 | Blood Glucose Decreased, Glaucoma
Adverse event was reported on Mar 12, 2010 by a Female patient taking Acarbose (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose decreased, glaucoma (What is glaucoma?). During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), GLIPIZIDE (Total Daily Dose: 10 Mg) (View Glipizide Review and Glipizide Label ).

6696645-9 | Pneumatosis Intestinalis, Portal Venous Gas
on Apr 19, 2010 Male patient from JAPAN , 91 years of age, weighting 132.3 lb, was diagnosed with diabetes mellitus and was treated with Acarbose (View Usage). Patient had the following side effects: pneumatosis intestinalis, portal venous gas. Acarbose dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), PRANLUKAST HYDRATE (View Pranlukast Hydrate Review and Pranlukast Hydrate Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6693218-9 | Scar, Skin Haemorrhage
on Apr 21, 2010 Female patient from UNITED STATES , 59 years of age, weighting 215.0 lb, was diagnosed with diabetes mellitus management and was treated with Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: scar (What is scar?), skin haemorrhage. Acarbose dosage: 1 Tablet 3 Times A Day.

6690821-7 | Diverticulum, Pneumatosis Intestinalis
Patient was taking Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: diverticulum, pneumatosis intestinalis on Apr 20, 2010 from Additional patient health information: Female patient , 65 years of age, was diagnosed with type 2 diabetes mellitus, diverticulitis, pneumatosis intestinalis and. Acarbose dosage: 150 Mg. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6047174-7 | Hypoglycaemia, Malaise, Speech Disorder
Adverse event was reported on Jan 19, 2009 by a Male patient taking Acarbose (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 80 years of age, Patient had the following side effects: hypoglycaemia, malaise, speech disorder. During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), METFORMIN HCL (Total Daily Dose: 3000 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), OLMIFON (View Olmifon Review and Olmifon Label ), EBIXA (View Ebixa Review and Ebixa Label ), MODOPAR (View Modopar Review and Modopar Label ). Patient was hospitalized.

6035484-9 | Cholestasis, Eosinophilia, Erythema, Leukocytosis, Ocular Icterus, Oedema Peripheral, Pyrexia
on Dec 19, 2008 Female patient from FRANCE , 44 years of age, was treated with Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: cholestasis, eosinophilia, erythema, leukocytosis, ocular icterus, oedema peripheral, pyrexia. Acarbose dosage: . Patient was hospitalized.

6029638-5 | Cholestasis, Eosinophilia, Erythema, Leukocytosis, Ocular Icterus, Oedema Peripheral, Pyrexia
on Dec 19, 2008 Female patient from FRANCE , 44 years of age, was treated with Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, eosinophilia, erythema, leukocytosis, ocular icterus, oedema peripheral, pyrexia. Acarbose dosage: . Patient was hospitalized.

6017289-8 | Fall, Hypoglycaemia
Patient was taking Acarbose (View Usage). Patient had the following side effects: fall (What is fall?), hypoglycaemia on Dec 16, 2008 from FRANCE Additional patient health information: Female patient , 88 years of age, was diagnosed with type 1 diabetes mellitus, cerebrovascular accident, hypertension and. Acarbose dosage: . During the same period patient was treated with HUMULIN N (View Humulin N Review and Humulin N Label ), PLAVIX (View Plavix Review and Plavix Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), LERCAN (View Lercan Review and Lercan Label ), TRINITRINE (View Trinitrine Review and Trinitrine Label ). Patient was hospitalized.

6010655-6 | Abdominal Pain, Acute Respiratory Distress Syndrome, Hyperthermia, Inflammation, Lactic Acidosis, Mechanical Ventilation, Oedema, Pyrexia, Renal Failure
Adverse event was reported on Feb 04, 2008 by a Female patient taking Acarbose (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 56 years of age, After Acarbose was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), acute respiratory distress syndrome, hyperthermia, inflammation, lactic acidosis, mechanical ventilation, oedema, pyrexia, renal failure. During the same period patient was treated with STAGID (Total Daily Dose: 2800 Mg) (View Stagid Review and Stagid Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (View Fosinopril Sodium And Hydrochlorothiazide Review and Fosinopril Sodium And Hydrochlorothiazide Label ), ATHYMIL (View Athymil Review and Athymil Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

5999430-6 | Hepatitis Cholestatic, Pyrexia
on Dec 04, 2008 Male patient from FRANCE , 44 years of age, was treated with Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis cholestatic, pyrexia. Acarbose dosage: Total Daily Dose: 150 Mg. During the same period patient was treated with METFORMIN (METFORMIN HYDROCHLORID) (Total Daily Dose: 2250 Mg) (View Metformin (metformin Hydrochlorid) Review and Metformin (metformin Hydrochlorid) Label ), AMARYL (View Amaryl Review and Amaryl Label ), ATACAND (View Atacand Review and Atacand Label ). Patient was hospitalized.

5935185-9 | Abdominal Pain, Acute Respiratory Distress Syndrome, Dialysis, Embolism, Hyperthermia, Inflammation, Intestinal Ischaemia, Lactic Acidosis, Mechanical Ventilation
on Feb 04, 2008 Female patient from FRANCE , 56 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Acarbose (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), acute respiratory distress syndrome, dialysis (What is dialysis?), embolism, hyperthermia, inflammation, intestinal ischaemia, lactic acidosis, mechanical ventilation. Acarbose dosage: . During the same period patient was treated with STAGID (Total Daily Dose: 2800 Mg) (View Stagid Review and Stagid Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (View Fosinopril Sodium And Hydrochlorothiazide Review and Fosinopril Sodium And Hydrochlorothiazide Label ), ATHYMIL (View Athymil Review and Athymil Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

5894560-1 | Pancreatitis Acute
Patient was taking Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: pancreatitis acute on Aug 06, 2008 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus and. Acarbose dosage: Total Daily Dose: 100 Mg Unit Dose: 50 Mg. During the same period patient was treated with GLIMEPIRIDE (Total Daily Dose: 6 Mg) (View Glimepiride Review and Glimepiride Label ), AVANDAMET (View Avandamet Review and Avandamet Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

5849182-5 | Pancreatitis Acute
Adverse event was reported on Aug 06, 2008 by a Female patient taking Acarbose (View Usage) (Dosage: Total Daily Dose: 100 Mg Unit Dose: 50 Mg) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 60 years of age, weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: pancreatitis acute. During the same period patient was treated with GLIMEPIRIDE (Total Daily Dose: 6 Mg) (View Glimepiride Review and Glimepiride Label ), AVANDAMET (View Avandamet Review and Avandamet Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5831980-5 | Pancreatitis Acute
on Jul 22, 2008 Female patient from UNITED STATES , 60 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus and was treated with Acarbose (View Usage). Patient had the following side effects: pancreatitis acute. Acarbose dosage: Total Daily Dose: 100 Mg Unit Dose: 50 Mg. During the same period patient was treated with GLIMEPIRIDE (Total Daily Dose: 6 Mg) (View Glimepiride Review and Glimepiride Label ), AVANDAMET (View Avandamet Review and Avandamet Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5824193-4 | Pancreatitis Acute
on Jul 10, 2008 Female patient from FRANCE , 60 years of age, weighting 138.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: pancreatitis acute. Acarbose dosage: Unit Dose: 50 Mg. During the same period patient was treated with AVANDAMET (Unit Dose: 1004 Mg) (View Avandamet Review and Avandamet Label ), GLIMEPIRIDE (Unit Dose: 9 Mg) (View Glimepiride Review and Glimepiride Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5819528-2 | Pancreatitis Acute
Patient was taking Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute on Jul 10, 2008 from FRANCE Additional patient health information: Female patient , 60 years of age, weighting 138.9 lb, was diagnosed with type 2 diabetes mellitus and. Acarbose dosage: Unit Dose: 50 Mg. During the same period patient was treated with AVANDAMET (Unit Dose: 1004 Mg) (View Avandamet Review and Avandamet Label ), GLIMEPIRIDE (Unit Dose: 9 Mg) (View Glimepiride Review and Glimepiride Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

5796824-9 | Diarrhoea, Nausea
Adverse event was reported on Jun 30, 2008 by a Male patient taking Acarbose (View Usage) (Dosage: 25 Mg Tid Po) . Location: UNITED STATES , 43 years of age, weighting 281.9 lb, Patient had the following side effects: diarrhoea, nausea (What is nausea?). Patient was hospitalized.

5571475-X | Abasia, Blood Creatine Phosphokinase Increased, Cardiac Arrest, Dyschezia, Fatigue, Hepatic Failure, Hypoaesthesia, Insomnia, Ischaemia
on Dec 20, 2007 Male patient from CHINA , 55 years of age, was diagnosed with hypercholesterolaemia and was treated with Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: abasia, blood creatine phosphokinase increased, cardiac arrest (What is cardiac arrest?), dyschezia, fatigue, hepatic failure, hypoaesthesia, insomnia, ischaemia. Acarbose dosage: . During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LESCOL (40 Mg, Qd) (View Lescol Review and Lescol Label ). Patient was hospitalized.

5537462-2 | Blood Alcohol Increased, Road Traffic Accident
on Nov 26, 2007 Male patient from POLAND , 25 years of age, was diagnosed with diabetes mellitus, hypertension and was treated with Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: blood alcohol increased, road traffic accident. Acarbose dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), PRESTARIUM (View Prestarium Review and Prestarium Label ), DIUREZIN (View Diurezin Review and Diurezin Label ). Patient was hospitalized.

5534364-2 | Blood Alcohol Increased, Road Traffic Accident
Patient was taking Acarbose (View Usage). Patient had the following side effects: blood alcohol increased, road traffic accident on Nov 26, 2007 from POLAND Additional patient health information: Male patient , 25 years of age, was diagnosed with diabetes mellitus, hypertension and. Acarbose dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), PRESTARIUM (View Prestarium Review and Prestarium Label ), DIUREZIN (View Diurezin Review and Diurezin Label ). Patient was hospitalized.

5524586-9 | Pancreatitis Acute
Adverse event was reported on Nov 09, 2007 by a Female patient taking Acarbose (View Usage) (Dosage: Unit Dose: 50 Mg) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 60 years of age, weighting 138.9 lb, After Acarbose was administered, patient had the following side effects: pancreatitis acute. During the same period patient was treated with AVANDAMET (Unit Dose: 1004 Mg) (View Avandamet Review and Avandamet Label ), GLIMEPIRIDE (Unit Dose: 6 Mg) (View Glimepiride Review and Glimepiride Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5512168-4 | Abasia, Blood Creatine Phosphokinase Increased, Cardiac Arrest, Dyschezia, Fatigue, Hepatic Failure, Hypoaesthesia, Insomnia, Ischaemia
on Nov 07, 2007 Male patient from CHINA , 55 years of age, was diagnosed with hypercholesterolaemia and was treated with Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, blood creatine phosphokinase increased, cardiac arrest (What is cardiac arrest?), dyschezia, fatigue, hepatic failure, hypoaesthesia, insomnia, ischaemia. Acarbose dosage: . During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LESCOL (40 Mg, Qd) (View Lescol Review and Lescol Label ). Patient was hospitalized.

5506074-9 | Abasia, Blood Creatine Phosphokinase Increased, Cardiac Arrest, Dyschezia, Fatigue, Hypoaesthesia, Insomnia, Ischaemia, Mechanical Ventilation
on Oct 30, 2007 Male patient from CHINA , 55 years of age, was diagnosed with hypercholesterolaemia and was treated with Acarbose (View Usage). Patient had the following side effects: abasia, blood creatine phosphokinase increased, cardiac arrest (What is cardiac arrest?), dyschezia, fatigue, hypoaesthesia, insomnia, ischaemia, mechanical ventilation. Acarbose dosage: . During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LESCOL (40 Mg, Qd) (View Lescol Review and Lescol Label ). Patient was hospitalized.

5503810-2 | Abasia, Dyschezia, Hypoaesthesia, Muscular Weakness, Myalgia, Pain In Extremity, Urinary Retention
Patient was taking Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: abasia, dyschezia, hypoaesthesia, muscular weakness, myalgia, pain in extremity, urinary retention on Oct 27, 2007 from CHINA Additional patient health information: Male patient , 55 years of age, was diagnosed with hypercholesterolaemia and. Acarbose dosage: . During the same period patient was treated with PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LESCOL (40 Mg, Qd) (View Lescol Review and Lescol Label ). Patient was hospitalized.

5464039-X | Asthenia, Hepatitis Cholestatic, Jaundice, Nausea
Adverse event was reported on Sep 06, 2007 by a Female patient taking Acarbose (View Usage) (Dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg) was diagnosed with type 2 diabetes mellitus, myelodysplastic syndrome and. Location: FRANCE , 57 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, hepatitis cholestatic, jaundice (What is jaundice?), nausea (What is nausea?). During the same period patient was treated with NILEVAR (Total Daily Dose: 60 Mg Unit Dose: 10 Mg) (View Nilevar Review and Nilevar Label ), AMARYL (Total Daily Dose: 4 Mg Unit Dose: 4 Mg) (View Amaryl Review and Amaryl Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ), SPECIAFOLDINE (Total Daily Dose: 20 Mg) (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

5455281-2 | Asthenia, Hepatitis Cholestatic, Jaundice, Nausea
on Sep 06, 2007 Female patient from FRANCE , 57 years of age, was diagnosed with type 2 diabetes mellitus, myelodysplastic syndrome and was treated with Acarbose (View Usage). Patient had the following side effects: asthenia, hepatitis cholestatic, jaundice (What is jaundice?), nausea (What is nausea?). Acarbose dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with NILEVAR (Total Daily Dose: 60 Mg Unit Dose: 10 Mg) (View Nilevar Review and Nilevar Label ), AMARYL (Total Daily Dose: 4 Mg Unit Dose: 4 Mg) (View Amaryl Review and Amaryl Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ), SPECIAFOLDINE (Total Daily Dose: 20 Mg) (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

5442954-0 | Asthenia, Hepatitis Cholestatic, Jaundice, Nausea
on Aug 30, 2007 Female patient from FRANCE , 57 years of age, was diagnosed with type 2 diabetes mellitus, myelodysplastic syndrome and was treated with Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: asthenia, hepatitis cholestatic, jaundice (What is jaundice?), nausea (What is nausea?). Acarbose dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with NILEVAR (Total Daily Dose: 60 Mg Unit Dose: 10 Mg) (View Nilevar Review and Nilevar Label ), AMARYL (Total Daily Dose: 4 Mg Unit Dose: 4 Mg) (View Amaryl Review and Amaryl Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ), SPECIAFOLDINE (Total Daily Dose: 20 Mg) (View Speciafoldine Review and Speciafoldine Label ). Patient was hospitalized.

5425917-0 | Hepatic Steatosis, Pancreatitis Acute
Patient was taking Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic steatosis, pancreatitis acute on Aug 23, 2007 from FRANCE Additional patient health information: Female patient , 60 years of age, weighting 138.9 lb, was diagnosed with type 2 diabetes mellitus and. Acarbose dosage: Unit Dose: 50 Mg. During the same period patient was treated with AVANDAMET (Unit Dose: 1004 Mg) (View Avandamet Review and Avandamet Label ), GLIMEPIRIDE (Unit Dose: 6 Mg) (View Glimepiride Review and Glimepiride Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5391160-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cytolytic Hepatitis, Lung Disorder
Adverse event was reported on Jul 13, 2007 by a Female patient taking Acarbose (View Usage) (Dosage: ) was diagnosed with unevaluable event, deep vein thrombosis (What is deep vein thrombosis?) and. Location: FRANCE , 83 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, lung disorder. During the same period patient was treated with DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), MOGADON (View Mogadon Review and Mogadon Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREVISCAN (View Previscan Review and Previscan Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TRIATEC (View Triatec Review and Triatec Label ). Patient was hospitalized.

5368406-4 |
on Jun 22, 2007 Male patient from FRANCE , 68 years of age, weighting 198.4 lb, was diagnosed with unevaluable event and was treated with Acarbose (View Usage). . Acarbose dosage: . During the same period patient was treated with DIFFU K (View Diffu K Review and Diffu K Label ), TRIATEC (View Triatec Review and Triatec Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), VFEND (Total Daily Dose: 200 Mg) (View Vfend Review and Vfend Label ), TARCEVA (Total Daily Dose: 150 Mg) (View Tarceva Review and Tarceva Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ).

5314322-3 | Anorexia, Fall, Hyperkalaemia, Hyponatraemia, Renal Failure Acute
on Apr 23, 2007 Male patient from FRANCE , 79 years of age, was diagnosed with diabetes mellitus, unevaluable event and was treated with Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, fall (What is fall?), hyperkalaemia, hyponatraemia, renal failure acute. Acarbose dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with GLUCOPHAGE (Total Daily Dose: 3 G Unit Dose: 500 Mg) (View Glucophage Review and Glucophage Label ), LASIX (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Lasix Review and Lasix Label ), LESCOL (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Lescol Review and Lescol Label ). Patient was hospitalized.

5306951-8 | Anorexia, Fall, Hyperkalaemia, Hyponatraemia, Renal Failure Acute
Patient was taking Acarbose (View Usage). Patient had the following side effects: anorexia, fall (What is fall?), hyperkalaemia, hyponatraemia, renal failure acute on Apr 02, 2007 from FRANCE Additional patient health information: Male patient , 79 years of age, was diagnosed with diabetes mellitus, unevaluable event and. Acarbose dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg. During the same period patient was treated with GLUCOPHAGE (Total Daily Dose: 3 G Unit Dose: 500 Mg) (View Glucophage Review and Glucophage Label ), LASIX (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Lasix Review and Lasix Label ), LESCOL (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Lescol Review and Lescol Label ). Patient was hospitalized.

5306948-8 | Alanine Aminotransferase Increased, Arrhythmia, Aspartate Aminotransferase Increased, Cardiac Failure, Cytolytic Hepatitis, Lung Disorder, Vertigo
Adverse event was reported on Mar 26, 2007 by a Female patient taking Acarbose (View Usage) (Dosage: ) was diagnosed with unevaluable event, deep vein thrombosis (What is deep vein thrombosis?) and. Location: FRANCE , 83 years of age, After Acarbose was administered, patient had the following side effects: alanine aminotransferase increased, arrhythmia (What is arrhythmia?), aspartate aminotransferase increased, cardiac failure, cytolytic hepatitis, lung disorder, vertigo. During the same period patient was treated with DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ), TAHOR (View Tahor Review and Tahor Label ), MOGADON (View Mogadon Review and Mogadon Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREVISCAN (View Previscan Review and Previscan Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TRIATEC (View Triatec Review and Triatec Label ). Patient was hospitalized.

5306930-0 | Teratospermia
on Apr 05, 2007 Male patient from FRANCE , 40 years of age, was diagnosed with unevaluable event and was treated with Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: teratospermia. Acarbose dosage: .

5223798-1 | Renal Failure Acute
on Jan 19, 2007 Female patient from FRANCE , 81 years of age, was diagnosed with unevaluable event and was treated with Acarbose (View Usage). Patient had the following side effects: renal failure acute. Acarbose dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NOVONORM (View Novonorm Review and Novonorm Label ), FOZITEC (View Fozitec Review and Fozitec Label ), HYDREA (View Hydrea Review and Hydrea Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ). Patient was hospitalized.

5223786-5 | Allergic Oedema, Atrial Fibrillation, Dyspnoea, Infection, Laryngeal Oedema, Tongue Oedema
Patient was taking Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: allergic oedema, atrial fibrillation (What is atrial fibrillation?), dyspnoea, infection (What is infection?), laryngeal oedema, tongue oedema on Jan 19, 2007 from FRANCE Additional patient health information: Female patient , 75 years of age, weighting 242.5 lb, was diagnosed with diabetes mellitus, hyperuricaemia, hypertension, unevaluable event and. Acarbose dosage: Total Daily Dose: 50 Mg Unit Dose: 50 Mg. During the same period patient was treated with ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), TAREG (View Tareg Review and Tareg Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), TRIATEC (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Triatec Review and Triatec Label ), LASIX (View Lasix Review and Lasix Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ). Patient was hospitalized.

5214259-4 | Renal Failure Acute
Adverse event was reported on Jan 15, 2007 by a Female patient taking Acarbose (View Usage) (Dosage: ) was diagnosed with unevaluable event and. Location: FRANCE , 81 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NOVONORM (View Novonorm Review and Novonorm Label ), FOZITEC (View Fozitec Review and Fozitec Label ), HYDREA (View Hydrea Review and Hydrea Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ). Patient was hospitalized.

5210338-6 | Allergic Oedema, Dyspnoea, Laryngeal Oedema, Tongue Oedema
on Jan 10, 2007 Female patient from FRANCE , 75 years of age, weighting 242.5 lb, was diagnosed with diabetes mellitus, hyperuricaemia, hypertension, unevaluable event and was treated with Acarbose (View Usage). Patient had the following side effects: allergic oedema, dyspnoea, laryngeal oedema, tongue oedema. Acarbose dosage: Total Daily Dose: 50 Mg Unit Dose: 50 Mg. During the same period patient was treated with ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), TAREG (View Tareg Review and Tareg Label ), BIPRETERAX (View Bipreterax Review and Bipreterax Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), TRIATEC (Total Daily Dose: 5 Mg Unit Dose: 5 Mg) (View Triatec Review and Triatec Label ), LASIX (View Lasix Review and Lasix Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ). Patient was hospitalized.

5210337-4 | Hypoglycaemia, Malaise, Renal Failure Acute
on Jan 10, 2007 Female patient from FRANCE , 72 years of age, was diagnosed with diabetes mellitus, unevaluable event, duodenitis, atrial fibrillation (What is atrial fibrillation?), essential hypertension and was treated with Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: hypoglycaemia, malaise, renal failure acute. Acarbose dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg. During the same period patient was treated with KAYEXALATE (View Kayexalate Review and Kayexalate Label ), GLUCOPHAGE (Total Daily Dose: 3000 Mg Unit Dose: 1000 Mg) (View Glucophage Review and Glucophage Label ), OMEPRAZOLE (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Omeprazole Review and Omeprazole Label ), HEMIGOXINE NATIVELLE (Total Daily Dose: 0.125 Mg Unit Dose: 0.125 Mg) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), LASIX (Total Daily Dose: 80 Mg Unit Dose: 40 Mg) (View Lasix Review and Lasix Label ). Patient was hospitalized.

5202139-X | Hypoglycaemia, Malaise, Renal Failure Acute, Vomiting
Patient was taking Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, malaise, renal failure acute, vomiting on Dec 20, 2006 from FRANCE Additional patient health information: Female patient , 72 years of age, was diagnosed with diabetes mellitus, unevaluable event, duodenitis, atrial fibrillation (What is atrial fibrillation?), essential hypertension and. Acarbose dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg. During the same period patient was treated with KAYEXALATE (View Kayexalate Review and Kayexalate Label ), GLUCOPHAGE (Total Daily Dose: 3000 Mg Unit Dose: 1000 Mg) (View Glucophage Review and Glucophage Label ), OMEPRAZOLE (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Omeprazole Review and Omeprazole Label ), HEMIGOXINE NATIVELLE (Total Daily Dose: 0.125 Mg Unit Dose: 0.125 Mg) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), LASIX (Total Daily Dose: 80 Mg Unit Dose: 40 Mg) (View Lasix Review and Lasix Label ). Patient was hospitalized.

5200009-4 | Renal Failure Acute
Adverse event was reported on Dec 15, 2006 by a Female patient taking Acarbose (View Usage) (Dosage: ) was diagnosed with unevaluable event and. Location: FRANCE , 81 years of age, Patient had the following side effects: renal failure acute. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NOVONORM (View Novonorm Review and Novonorm Label ), FOZITEC (View Fozitec Review and Fozitec Label ), HYDREA (View Hydrea Review and Hydrea Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ). Patient was hospitalized.

5198838-9 | Disease Progression, Feeding Disorder, Hypoglycaemia, Malaise, Renal Failure Acute, Vomiting
on Dec 20, 2006 Female patient from FRANCE , 72 years of age, was diagnosed with diabetes mellitus, unevaluable event, duodenitis, atrial fibrillation (What is atrial fibrillation?), essential hypertension and was treated with Acarbose (View Usage). After Acarbose was administered, patient had the following side effects: disease progression, feeding disorder, hypoglycaemia, malaise, renal failure acute, vomiting. Acarbose dosage: Total Daily Dose: 150 Mg Unit Dose: 50 Mg. During the same period patient was treated with KAYEXALATE (View Kayexalate Review and Kayexalate Label ), GLUCOPHAGE (Total Daily Dose: 3000 Mg Unit Dose: 1000 Mg) (View Glucophage Review and Glucophage Label ), OMEPRAZOLE (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Omeprazole Review and Omeprazole Label ), HEMIGOXINE NATIVELLE (Total Daily Dose: 0.125 Mg Unit Dose: 0.125 Mg) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), LASIX (Total Daily Dose: 80 Mg Unit Dose: 40 Mg) (View Lasix Review and Lasix Label ). Patient was hospitalized.

5198837-7 | Renal Failure Acute
on Dec 15, 2006 Female patient from FRANCE , 81 years of age, was diagnosed with unevaluable event and was treated with Acarbose (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Acarbose dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NOVONORM (View Novonorm Review and Novonorm Label ), FOZITEC (View Fozitec Review and Fozitec Label ), HYDREA (View Hydrea Review and Hydrea Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ). Patient was hospitalized.

5198690-1 | Hypoglycaemia, Malaise, Renal Failure Acute, Self-induced Vomiting
Patient was taking Acarbose (View Usage). Patient had the following side effects: hypoglycaemia, malaise, renal failure acute, self-induced vomiting on Dec 26, 2006 from FRANCE Additional patient health information: Female patient , 72 years of age, was diagnosed with diabetes mellitus, hypertension, atrial fibrillation (What is atrial fibrillation?), atrial flutter, duodenitis and. Acarbose dosage: 150 Mg. During the same period patient was treated with LASIX (80 Mg) (View Lasix Review and Lasix Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), KAYEXALATE (30 G) (View Kayexalate Review and Kayexalate Label ). Patient was hospitalized.